Aurora Investment Counsel Gilead Sciences, Inc. Transaction History

Aurora Investment Counsel

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $993,247 - $1.16 Million	-15,309 Closed	0 $0
Q1 2018 Apr 09, 2018	SELL	$72.84 - $88.8 $129,218 - $157,531	-1,774 Reduced 10.38%	15,309 $1.15 Million
Q4 2017 Jan 04, 2018	BUY	$71.15 - $83.52 $1.22 Million - $1.43 Million	17,083	17,083 $1.22 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.